Peter McArdle

1.1k total citations
26 papers, 879 citations indexed

About

Peter McArdle is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Peter McArdle has authored 26 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Peter McArdle's work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Cancer, Lipids, and Metabolism (7 papers) and Prostate Cancer Treatment and Research (5 papers). Peter McArdle is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (9 papers), Cancer, Lipids, and Metabolism (7 papers) and Prostate Cancer Treatment and Research (5 papers). Peter McArdle collaborates with scholars based in United Kingdom, Australia and United States. Peter McArdle's co-authors include Donald C. McMillan, A. M. McNicol, Khalid Canna, Ruth F. McKee, C S McArdle, Michael Aitchison, Mark A. Underwood, Tahir Qayyum, E. Bromwich and Joanne Edwards and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Peter McArdle

25 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter McArdle United Kingdom 14 518 246 227 159 154 26 879
Diana Flores‐Estrada Mexico 16 477 0.9× 284 1.2× 118 0.5× 111 0.7× 119 0.8× 41 1.0k
Christina L. Costantino United States 15 282 0.5× 147 0.6× 145 0.6× 144 0.9× 140 0.9× 26 876
Ya‐Hui Yu China 15 277 0.5× 179 0.7× 177 0.8× 127 0.8× 130 0.8× 53 777
M. Castro Argentina 16 254 0.5× 248 1.0× 93 0.4× 240 1.5× 126 0.8× 26 1000
M. Lloret Spain 20 311 0.6× 205 0.8× 179 0.8× 56 0.4× 183 1.2× 50 890
Alexander Perathoner Austria 18 323 0.6× 347 1.4× 75 0.3× 265 1.7× 504 3.3× 45 1.4k
A. Eisenhardt Germany 16 139 0.3× 97 0.4× 103 0.5× 71 0.4× 163 1.1× 48 729
Mira Wollner Israel 14 441 0.9× 334 1.4× 66 0.3× 104 0.7× 53 0.3× 29 836
Huichuan Yu China 16 392 0.8× 125 0.5× 128 0.6× 101 0.6× 206 1.3× 61 880

Countries citing papers authored by Peter McArdle

Since Specialization
Citations

This map shows the geographic impact of Peter McArdle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McArdle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McArdle more than expected).

Fields of papers citing papers by Peter McArdle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McArdle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McArdle. The network helps show where Peter McArdle may publish in the future.

Co-authorship network of co-authors of Peter McArdle

This figure shows the co-authorship network connecting the top 25 collaborators of Peter McArdle. A scholar is included among the top collaborators of Peter McArdle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter McArdle. Peter McArdle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Charles S., et al.. (2023). Patient and Clinician Experience of Using Telehealth During the 'COVID-19 Pandemic in a Public Mental Health Service in Australia. Schizophrenia Bulletin Open. 4(1). sgad016–sgad016.
2.
Qayyum, Tahir, Peter McArdle, James J. Going, et al.. (2013). A Prospective Study of the Role of Inflammation in Bladder Cancer. Current Urology. 6(4). 189–193. 13 indexed citations
3.
Qayyum, Tahir, et al.. (2013). The Accuracy of Magnetic Resonance Imaging in Radical Prostatectomy. Current Urology. 7(2). 62–64. 1 indexed citations
4.
Qayyum, Tahir, Peter McArdle, Clare Orange, et al.. (2013). Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?. SpringerPlus. 2(1). 378–378. 9 indexed citations
5.
Qayyum, Tahir, Peter McArdle, Gavin W.A. Lamb, et al.. (2012). Expression and prognostic significance of Src family members in renal clear cell carcinoma. British Journal of Cancer. 107(5). 856–863. 30 indexed citations
6.
Mackenzie, Lewis, Sophia Hatziieremia, Claire Adams, et al.. (2012). Nuclear factor κB predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor. Human Pathology. 43(9). 1491–1500. 15 indexed citations
7.
Qayyum, Tahir, Mark Duncan, Peter McArdle, et al.. (2012). The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder. British Journal of Cancer. 106(6). 1187–1195. 15 indexed citations
8.
Qayyum, Tahir, Peter McArdle, Gavin W.A. Lamb, et al.. (2012). Prospective Study of the Role of Inflammation in Renal Cancer. Urologia Internationalis. 88(3). 277–281. 27 indexed citations
9.
Qayyum, Tahir, Peter McArdle, James J. Going, et al.. (2011). Is the Presence or Absence of Tumour Necrosis a Significant Predictor of Survival in Renal Cell Cancer?. Urologia Internationalis. 88(1). 79–83. 2 indexed citations
10.
McArdle, Peter, Tahir Qayyum, & Donald C. McMillan. (2010). Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up. Urologia Internationalis. 84(4). 430–435. 28 indexed citations
11.
Tiller, John, David Ames, Henry Brodaty, et al.. (2008). Antipsychotic use in the elderly: What doctors say they do, and what they do. Australasian Journal on Ageing. 27(3). 134–142. 6 indexed citations
12.
McArdle, Peter, et al.. (2007). Proptosis – An Uncommon Presentation of Orbital Metastases Secondary to Prostate Cancer. Urologia Internationalis. 79(4). 374–375. 3 indexed citations
13.
Talwar, Dinesh, Peter McArdle, Cathy Williamson, et al.. (2005). Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. International Journal of Cancer. 118(4). 1051–1053. 31 indexed citations
14.
Canna, Khalid, Peter McArdle, Donald C. McMillan, et al.. (2005). The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. British Journal of Cancer. 92(4). 651–654. 196 indexed citations
15.
McArdle, Peter, et al.. (2004). The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. British Journal of Cancer. 91(3). 541–543. 91 indexed citations
16.
McArdle, Peter, Donald C. McMillan, Naveed Sattar, Andrew Wallace, & Mark A. Underwood. (2004). The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease. British Journal of Cancer. 91(10). 1755–1757. 31 indexed citations
17.
Bromwich, E., Peter McArdle, Khalid Canna, et al.. (2003). The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. British Journal of Cancer. 89(10). 1906–1908. 133 indexed citations
18.
Crews, W. David, et al.. (1997). Neuropsychological Dysfunction in Severe Accidental Electrical Shock: Two Case Reports. Applied Neuropsychology. 4(4). 208–219. 17 indexed citations
19.
McArdle, Peter, et al.. (1995). Pseudoleucocytosis due to incomplete erythrocyte lysis.. PubMed. 17(4). 347–8. 1 indexed citations
20.
Buamah, P K, Peter McArdle, Mark K. Bennett, Oliver James, & R Lendrum. (1986). A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma. Journal of Surgical Oncology. 32(2). 93–95. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Flores‐Estrada Breakdown of academic impact, for papers by Christina L. Costantino Breakdown of academic impact, for papers by Ya‐Hui Yu Breakdown of academic impact, for papers by M. Castro Breakdown of academic impact, for papers by M. Lloret Breakdown of academic impact, for papers by Alexander Perathoner Breakdown of academic impact, for papers by A. Eisenhardt Breakdown of academic impact, for papers by Mira Wollner Breakdown of academic impact, for papers by Huichuan Yu
Rankless by CCL
2026